• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析血小板动力学在肝细胞癌的诊断和预后评估中的作用。

Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma.

机构信息

Cardiovascular and Gastroenterological Surgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.

Department of Laboratory and Vascular Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8520, Japan.

出版信息

Can J Gastroenterol Hepatol. 2018 Jun 27;2018:9142672. doi: 10.1155/2018/9142672. eCollection 2018.

DOI:10.1155/2018/9142672
PMID:30050894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6040256/
Abstract

Liver pathophysiology can, directly and indirectly, impose morphological or biochemical abnormalities of the platelets. Conversely, platelets are also able to regulate the promitogenic and profibrotic signals on liver pathobiology. Platelet contribution to the liver pathophysiology is typically facilitated by the platelet-derived growth factors that are sequestered in different subsets of alpha and dense granules, and the release of these growth factors is synchronized according to the stage and type of liver disease or injury. Thus, platelets harbor clinically relevant information with potential diagnostic and prognostic implications in liver diseases. Hepatocellular carcinoma (HCC) largely influences the platelet kinetics, and a growing body of evidence has recognized its association with HCC occurrence or prognosis. This narrative review summarizes the progress made on implicating platelet as a diagnostic and prognostic tool for HCC; the review also dissects the contradictory results from earlier studies and reflects how combining platelet-based information may enable more reliable test for diagnostic and prognostic evaluation of HCC.

摘要

肝脏病理生理学可直接或间接导致血小板的形态或生化异常。相反,血小板也能够调节肝脏病理生物学中的促有丝分裂和促纤维化信号。血小板对肝脏病理生理学的贡献通常是由血小板衍生的生长因子介导的,这些生长因子被隔离在不同的α和致密颗粒亚群中,并且这些生长因子的释放根据肝病或损伤的阶段和类型而同步进行。因此,血小板具有与肝脏疾病相关的潜在诊断和预后意义的临床相关信息。肝细胞癌 (HCC) 极大地影响了血小板的动力学,越来越多的证据已经认识到它与 HCC 的发生或预后有关。本综述总结了将血小板作为 HCC 诊断和预后工具的研究进展;还分析了早期研究中相互矛盾的结果,并反映了如何结合基于血小板的信息可以为 HCC 的诊断和预后评估提供更可靠的检测方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/6040256/65ebb31e5271/CJGH2018-9142672.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/6040256/65ebb31e5271/CJGH2018-9142672.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/272a/6040256/65ebb31e5271/CJGH2018-9142672.001.jpg

相似文献

1
Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma.解析血小板动力学在肝细胞癌的诊断和预后评估中的作用。
Can J Gastroenterol Hepatol. 2018 Jun 27;2018:9142672. doi: 10.1155/2018/9142672. eCollection 2018.
2
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.乙肝/丙肝相关肝硬化患者与肝硬化合并肝细胞癌患者血浆和血小板中血管生成蛋白水平并无差异。
Platelets. 2015;26(6):577-82. doi: 10.3109/09537104.2014.961415. Epub 2014 Oct 2.
3
Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma.血小板与淋巴细胞比值在肝细胞癌患者中的临床病理及预后意义
Oncotarget. 2016 Dec 6;7(49):81830-81838. doi: 10.18632/oncotarget.13244.
4
Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.血小板与淋巴细胞比值是晚期肝细胞癌患者的一个预后因素。
Tumour Biol. 2015 Apr;36(4):2263-9. doi: 10.1007/s13277-014-2833-9. Epub 2014 Nov 21.
5
Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.血小板与淋巴细胞比值在肝细胞癌中的预后价值:一项荟萃分析
Sci Rep. 2016 Oct 14;6:35378. doi: 10.1038/srep35378.
6
Prognostic Value of Pre-Operative Platelet to Lymphocyte Ratio in Patients with Resected Primary Hepatocellular Carcinoma.术前血小板与淋巴细胞比值对原发性肝细胞癌切除患者的预后价值
Clin Lab. 2016 Nov 1;62(11):2191-2196. doi: 10.7754/Clin.Lab.2016.160414.
7
Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.血小板计数及基于血小板的模型对肝细胞癌复发的意义
World J Gastroenterol. 2015 May 14;21(18):5607-21. doi: 10.3748/wjg.v21.i18.5607.
8
Platelet Distribution Width in Hepatocellular Carcinoma.血小板分布宽度与肝细胞癌。
Med Sci Monit. 2018 Apr 24;24:2518-2523.
9
Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及预后营养指数作为巨大(≥10 cm)肝细胞癌肝切除术后早期死亡术前预测指标的意义
J Surg Oncol. 2016 May;113(6):621-7. doi: 10.1002/jso.24197. Epub 2016 Feb 10.
10
Association between platelet to lymphocyte ratio (PLR) and overall survival (OS) of hepatocellular carcinoma (HCC): A meta-analysis.血小板与淋巴细胞比值(PLR)与肝细胞癌(HCC)总生存期(OS)的相关性:一项荟萃分析。
Cell Mol Biol (Noisy-le-grand). 2017 Aug 30;63(8):30-32. doi: 10.14715/cmb/2017.63.8.7.

引用本文的文献

1
Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.基于动态对比增强磁共振成像的放射组学术前预测巨梁型/块状型肝细胞癌。
World J Gastroenterol. 2023 Apr 7;29(13):2001-2014. doi: 10.3748/wjg.v29.i13.2001.
2
Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy.停止肝炎活动可降低原发性根治性治疗后肝细胞癌的复发率。
J Pers Med. 2023 Feb 24;13(3):397. doi: 10.3390/jpm13030397.
3
The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in Diagnosis and Prognosis of HCC in Egyptian Patients.

本文引用的文献

1
Serum cytokine profiles predict survival benefits in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective cohort study.血清细胞因子谱预测索拉非尼治疗晚期肝细胞癌患者的生存获益:一项回顾性队列研究。
BMC Cancer. 2017 Dec 19;17(1):870. doi: 10.1186/s12885-017-3889-x.
2
Post-Resection Exhaustion of Intra-Platelet Serotonin: Also an Indicator of Early Hepatocellular Carcinoma Recurrence?血小板内血清素切除后耗竭:也是早期肝细胞癌复发的一个指标?
J Cancer. 2017 Oct 23;8(19):3984-3991. doi: 10.7150/jca.20971. eCollection 2017.
3
Perioperative von Willebrand factor dynamics are associated with liver regeneration and predict outcome after liver resection.
循环肿瘤胎儿 H19 衍生 miR-675 表达与组织 lncRNA-H19 表达在埃及患者 HCC 诊断和预后中的潜在应用。
Biomolecules. 2022 Dec 20;13(1):3. doi: 10.3390/biom13010003.
4
Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma.血小板计数低预示潜在可切除肝细胞癌患者生存时间缩短。
Curr Oncol. 2022 Feb 28;29(3):1475-1487. doi: 10.3390/curroncol29030124.
5
Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases.至死不渝——血小板在肝脏疾病中的多面角色。
Int J Mol Sci. 2021 Mar 18;22(6):3113. doi: 10.3390/ijms22063113.
6
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics.血小板与肝细胞癌:从实验室到临床的桥梁
Cancers (Basel). 2019 Oct 15;11(10):1568. doi: 10.3390/cancers11101568.
7
A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma.一种用于预测肝细胞癌患者肝切除术后肝功能衰竭的新模型。
PLoS One. 2019 Jul 3;14(7):e0219219. doi: 10.1371/journal.pone.0219219. eCollection 2019.
8
Predictive Value of Diminished Serum PDGF-BB after Curative Resection of Hepatocellular Cancer.肝细胞癌根治性切除术后血清血小板衍生生长因子-BB降低的预测价值
J Oncol. 2019 Jan 6;2019:1925315. doi: 10.1155/2019/1925315. eCollection 2019.
围手术期血管性血友病因子的动态变化与肝再生有关,并可预测肝切除术后的结局。
Hepatology. 2018 Apr;67(4):1516-1530. doi: 10.1002/hep.29651. Epub 2018 Feb 27.
4
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.2015 年全球疾病负担研究:1990 年至 2015 年全球、区域和国家一级原发性肝癌及相关病因负担。
JAMA Oncol. 2017 Dec 1;3(12):1683-1691. doi: 10.1001/jamaoncol.2017.3055.
5
Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans.血小板内 5-羟色胺在人类肝再生和肿瘤复发中的双重作用。
J Hepatol. 2017 Dec;67(6):1243-1252. doi: 10.1016/j.jhep.2017.08.009. Epub 2017 Aug 24.
6
Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival.血小板与中性粒细胞比值变化可预测巴塞罗那临床肝癌分期A期肝细胞癌的生存率。
Medicine (Baltimore). 2017 Aug;96(33):e7821. doi: 10.1097/MD.0000000000007821.
7
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.基于肿瘤驯化血小板的群体智能增强型非小细胞肺癌检测
Cancer Cell. 2017 Aug 14;32(2):238-252.e9. doi: 10.1016/j.ccell.2017.07.004.
8
Platelet RNA signatures for the detection of cancer.用于癌症检测的血小板RNA特征
Cancer Metastasis Rev. 2017 Jun;36(2):263-272. doi: 10.1007/s10555-017-9674-0.
9
Platelets, circulating tumor cells, and the circulome.血小板、循环肿瘤细胞与循环组学
Cancer Metastasis Rev. 2017 Jun;36(2):235-248. doi: 10.1007/s10555-017-9681-1.
10
Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.血小板计数、脾脏长度以及血小板计数与脾脏长度之比在慢性肝病或门静脉血栓形成患者食管静脉曲张诊断中的应用
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD008759. doi: 10.1002/14651858.CD008759.pub2.